Cargando…
Elimination of Schistosoma mansoni in infected mice by slow release of artemisone
The current treatment of schistosomiasis is based on the anti-helminthic drug praziquantel (PZQ). PZQ affects only the adult stages of schistosomes. In addition, resistance to PZQ is emerging. We suggest a drug, which could serve as a potential alternative or complement to PZQ, and as a means of tre...
Autores principales: | Gold, Daniel, Alian, Mohammed, Domb, Avraham, Karawani, Yara, Jbarien, Maysa, Chollet, Jacques, Haynes, Richard K., Wong, Ho Ning, Buchholz, Viola, Greiner, Andreas, Golenser, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430492/ https://www.ncbi.nlm.nih.gov/pubmed/28511056 http://dx.doi.org/10.1016/j.ijpddr.2017.05.002 |
Ejemplares similares
-
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
por: Golenser, Jacob, et al.
Publicado: (2020) -
Controlled release of artemisone for the treatment of experimental cerebral malaria
por: Golenser, Jacob, et al.
Publicado: (2017) -
Artemisone effective against murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010) -
Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy
por: Zech, Johanna, et al.
Publicado: (2020) -
Schistosoma mansoni infection reduces the incidence of murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010)